| Term | Count | % | | DRUG INEFFECTIVE | 4057 | 9.12% |
| TREATMENT FAILURE | 3076 | 6.91% |
| OCULAR HYPERAEMIA | 2321 | 5.22% |
| EYE IRRITATION | 1824 | 4.10% |
| MADAROSIS | 1383 | 3.11% |
| EYE PRURITUS | 1312 | 2.95% |
| ERYTHEMA OF EYELID | 1009 | 2.27% |
| EYE PAIN | 926 | 2.08% |
| HYPERSENSITIVITY | 849 | 1.91% |
| VISION BLURRED | 829 | 1.86% |
| INTRAOCULAR PRESSURE INCREASED | 709 | 1.59% |
| FATIGUE | 691 | 1.55% |
| OFF LABEL USE | 688 | 1.55% |
| HEADACHE | 656 | 1.47% |
| EYE SWELLING | 644 | 1.45% |
| DRY EYE | 643 | 1.45% |
| WRONG TECHNIQUE IN PRODUCT USAGE PROCESS | 582 | 1.31% |
| INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION | 539 | 1.21% |
| DYSPNOEA | 537 | 1.21% |
| EYELIDS PRURITUS | 529 | 1.19% |
| DIZZINESS | 511 | 1.15% |
| ERYTHEMA | 509 | 1.14% |
| NAUSEA | 495 | 1.11% |
| DIARRHOEA | 490 | 1.10% |
| INCORRECT DOSE ADMINISTERED | 489 | 1.10% |
| SKIN HYPERPIGMENTATION | 480 | 1.08% |
| VISUAL IMPAIRMENT | 455 | 1.02% |
| FALL | 454 | 1.02% |
| ASTHENIA | 437 | 0.98% |
| EYELID OEDEMA | 419 | 0.94% |
| PRURITUS | 418 | 0.94% |
| WRONG TECHNIQUE IN DRUG USAGE PROCESS | 404 | 0.91% |
| PAIN | 390 | 0.88% |
| DEATH | 374 | 0.84% |
| LACRIMATION INCREASED | 373 | 0.84% |
| EYELID IRRITATION | 370 | 0.83% |
| PRODUCT DOSE OMISSION ISSUE | 352 | 0.79% |
| RASH | 347 | 0.78% |
| CATARACT | 330 | 0.74% |
| INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION | 326 | 0.73% |
| GLAUCOMA | 320 | 0.72% |
| MALAISE | 316 | 0.71% |
| EYE DISCHARGE | 304 | 0.68% |
| THERAPEUTIC RESPONSE DECREASED | 300 | 0.67% |
| GROWTH OF EYELASHES | 295 | 0.66% |
| SKIN DISCOLOURATION | 290 | 0.65% |
| VISUAL ACUITY REDUCED | 284 | 0.64% |
| PNEUMONIA | 283 | 0.64% |
| TRICHORRHEXIS | 281 | 0.63% |
| BLEPHARAL PIGMENTATION | 279 | 0.63% |
| DRUG DOSE OMISSION | 272 | 0.61% |
| ARTHRALGIA | 270 | 0.61% |
| VOMITING | 269 | 0.60% |
| PAIN IN EXTREMITY | 264 | 0.59% |
| COUGH | 261 | 0.59% |
| DRUG HYPERSENSITIVITY | 256 | 0.58% |
| WEIGHT DECREASED | 253 | 0.57% |
| ACCIDENTAL EXPOSURE TO PRODUCT | 247 | 0.56% |
| INSOMNIA | 243 | 0.55% |
| PRODUCT QUALITY ISSUE | 237 | 0.53% |
| HYPERTENSION | 235 | 0.53% |
| EYE DISORDER | 218 | 0.49% |
| FOREIGN BODY SENSATION IN EYES | 212 | 0.48% |
| DECREASED APPETITE | 205 | 0.46% |
| CONSTIPATION | 196 | 0.44% |
| BLOOD PRESSURE INCREASED | 195 | 0.44% |
| BACK PAIN | 194 | 0.44% |
| OCULAR DISCOMFORT | 193 | 0.43% |
| PRODUCT PACKAGING QUANTITY ISSUE | 190 | 0.43% |
| GAIT DISTURBANCE | 188 | 0.42% |
| HAIR GROWTH ABNORMAL | 188 | 0.42% |
| ANAEMIA | 186 | 0.42% |
| ANXIETY | 184 | 0.41% |
| HYPOTENSION | 177 | 0.40% |
| CONDITION AGGRAVATED | 174 | 0.39% |
| PHOTOPHOBIA | 172 | 0.39% |
| PYREXIA | 172 | 0.39% |
| FEELING ABNORMAL | 169 | 0.38% |
| URINARY TRACT INFECTION | 169 | 0.38% |
| CONFUSIONAL STATE | 157 | 0.35% |
| DEPRESSION | 157 | 0.35% |
| PERIPHERAL SWELLING | 157 | 0.35% |
| SOMNOLENCE | 153 | 0.34% |
| SWELLING OF EYELID | 153 | 0.34% |
| EXPIRED PRODUCT ADMINISTERED | 152 | 0.34% |
| MYALGIA | 152 | 0.34% |
| ABDOMINAL DISCOMFORT | 151 | 0.34% |
| BLINDNESS | 150 | 0.34% |
| CHEST PAIN | 149 | 0.33% |
| CEREBROVASCULAR ACCIDENT | 148 | 0.33% |
| DRUG ADMINISTERED AT INAPPROPRIATE SITE | 148 | 0.33% |
| EYELID PAIN | 148 | 0.33% |
| OEDEMA PERIPHERAL | 147 | 0.33% |
| NASOPHARYNGITIS | 146 | 0.33% |
| ALOPECIA | 144 | 0.32% |
| ATRIAL FIBRILLATION | 144 | 0.32% |
| BLOOD GLUCOSE INCREASED | 142 | 0.32% |
| WEIGHT INCREASED | 141 | 0.32% |
| ABDOMINAL PAIN UPPER | 140 | 0.31% |
| BLEPHARITIS | 140 | 0.31% |
| Total | 44487 | |